Dr.Reddy’s receives approval for aspirin and extended-release dipyridamole capsules

摘要

Dr.Reddy’s Laboratories Ltd.has announced receipt of approval from the US FDA for aspirin and extended-release dipyridamole capsules in the US market.The drug is a therapeu-tic equivalent generic version of Ag-grenox capsules from Boehringer In-gelheim,and will be made available in 25 mg/200 mg strength with 60 count bottle size.